JPRN-UMIN000021469已完成未知
Randomized phase II study exploring better regimen of hepatic arterial infusion chemotherapy for the patients with advanced hepatocellular carcinoma - Randomized phase II study exploring better regimen of hepatic arterial infusion chemotherapy for the patients with advanced hepatocellular carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •technically unsuitable for HAIC; extrahepatic lesion; refractory ascites or pleural effusion, history of hepatic encephalopathy, risky varices; double cancer; metastases to central nervous system; severe complication; pregnant or lactating women, or women of childbearing potential; mental disorder; allergy for fluorouracil, cisplatin, or contrast agent of CT or/and MRI
研究者
相似试验
进行中（未招募）
1 期
_Patients with liver-only non resectable colorectal metastases.EUCTR2016-001493-15-FRICANCER140
进行中（未招募）
1 期
A trial investigating different treatment plans of the medication nab-Paclitaxel, a chemotherapeutic agent in patients with breast cancer that has spread to other parts of the body.Patients with histologically or cytologically confirmed HER2-negative metastatic (stage IV) breast cancer who have not received chemotherapy for metastatic breast cancer.MedDRA version: 15.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-003058-10-SIInternational Breast Cancer Study Group (IBCSG)240
进行中（未招募）
1 期
A trial investigating different treatment plans of the medication nab-Paclitaxel, a chemotherapeutic agent in patients with breast cancer that has spread to other parts of the body.EUCTR2012-003058-10-ESInternational Breast Cancer Study Group (IBCSG)240
进行中（未招募）
1 期
A trial investigating different treatment plans of the medication nab-Paclitaxel, a chemotherapeutic agent in patients with breast cancer that has spread to other parts of the body.EUCTR2012-003058-10-ITInternational Breast Cancer Study Group (IBCSG)240
进行中（未招募）
1 期
A trial investigating different treatment plans of the medication nab-Paclitaxel, a chemotherapeutic agent in patients with breast cancer that has spread to other parts of the body.Patients with histologically or cytologically confirmed HER2-negative metastatic (stage IV) breast cancer who have not received chemotherapy for metastatic breast cancer.MedDRA version: 17.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-003058-10-BEInternational Breast Cancer Study Group (IBCSG)258